For years, the antipsychotic olanzapine (Zyprexa, Lilly) has been used off label for chemotherapy-induced nausea and vomiting (CINV), but the currently recommended 10-mg dose causes daytime sedation.
December 15, 2009 — The US Food and Drug Administration (FDA) has approved olanzapine extended-release intramuscular injection (Zyprexa Relprevv, Eli Lilly & Company) for the treatment of ...
SILVER SPRING, Md. — The Food and Drug Administration has approved the first generic versions of two drugs made by Eli Lilly for treating schizophrenia and bipolar disorder, the agency said Monday.
Please provide your email address to receive an email when new articles are posted on . “[Olanzapine intramuscular] (OLZ IM) administration requires either restraint or some level of patient ...
Long-acting injection provides therapeutic olanzapine exposure for up to four weeks INDIANAPOLIS, Dec 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The U.S. Food and Drug Administration ...
Nausea and vomiting caused by chemotherapy remain some of the most challenging side effects of cancer treatment, especially for patients receiving highly emetogenic regimens such as ...